| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,835 | 4,885 | 16:53 | |
| 4,835 | 4,885 | 16:53 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Median Technologies to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis LCS | 198 | Business Wire | Webcasts on February 26, 2026, at 5:45 pm CET (held in French): sign-up link and 6:45 pm CET/12:45 pm ET (held in English): sign-up link
Regulatory News:
Median Technologies (FR0011049824, ALMDT... ► Artikel lesen | |
| 18.02. | Median Technologies: FDA Clearance Sets Stage for U.S. Commercialization of eyonis LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc. | 402 | Business Wire | Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis LCS
Established U.S. commercial and clinical infrastructure combined with Medicare reimbursement pathway... ► Artikel lesen | |
| 12.02. | Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis LCS Software as a Medical Device in the United States | 345 | Business Wire | The collaboration follows FDA 510(k) clearance for eyonis LCS and aims to integrate high-performance lung cancer screening detection and diagnosis device into the clinical workflow through the Tempus... ► Artikel lesen | |
| 11.02. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31, 2026 | 301 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 09.02. | Median Technologies receives FDA clearance for lung cancer AI tool | 8 | Investing.com | ||
| 09.02. | Median Technologies Receives FDA 510(k) Clearance for eyonis LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening | 495 | Business Wire | eyonis LCS aims to redefine lung cancer screening by supporting diagnosis at early, curable stages, while reducing false positives to avoid unnecessary follow-up procedures, and has the potential... ► Artikel lesen | |
| 19.01. | Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026 | 322 | Business Wire | Record iCRO bookings in 2025; order backlog at an all-time high of €76.6 million despite negative forex impact of (6.5) million
2025 revenue of €23.5 million, up 2.6% vs 2024 despite negative... ► Artikel lesen | |
| MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 14.01. | Median Technologies: H1 2026 Financial Communication Calendar | 316 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software... ► Artikel lesen | |
| 07.01. | Half Year Median Technologies Liquidity Contract Statement | 587 | Business Wire | Regulatory News:
Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following resources were... ► Artikel lesen | |
| 05.01. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31, 2025 | 243 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 08.12.25 | Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis LCS to Patients Across the U.S. and Europe | 338 | Business Wire | Non-exclusive commercial agreement for the distribution of eyonis LCS in the United States and Europe
The agreement will become effective upon FDA 510(k) clearance
Partner's robust... ► Artikel lesen | |
| 03.12.25 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30, 2025 | 331 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
| 25.11.25 | Median Technologies to Showcase AI-Powered Software as a Medical Device eyonis LCS for Lung Cancer Screening at the RSNA 2025 Annual Meeting | 447 | Business Wire | Peer-reviewed scientific presentation: "Rethinking Lung Cancer Screening: Longitudinal AI/ML Diagnostics beyond Nodule Size Growth"
AI Theater Presentation: "eyonis LCS: Transforming Lung... ► Artikel lesen | |
| 13.11.25 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31, 2025 | 325 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 03.11.25 | Lion Point Capital founder joins Median Technologies board | 3 | Investing.com | ||
| 03.11.25 | Median Technologies Appoints Didric Cederholm to Its Board of Directors | 343 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software... ► Artikel lesen | |
| 28.10.25 | Median Technologies: €19 Million EIB Financing Raised To Boost AI-Enabled Cancer Diagnosis Platform | 2 | pulse2.com | ||
| 23.10.25 | Median Technologies Reports First-Half 2025 Financial Results and Provides Key Q3 2025 Business Results | 469 | Business Wire | Operating loss reduced by €4 million in first six months of 2025 versus H1 2024, highlighting improved corporate efficiency
H1 2025 revenues at €11.3 million, vs €10.9 million in H1 2024... ► Artikel lesen | |
| 21.10.25 | Median Technologies Receives €19 Million From the European Investment Bank, Corresponding to the First Tranche Under the 2025 Loan Facility | 368 | Business Wire | Proceeds to support the commercial launch of eyonis®LCS in the U.S. and Europe, and accelerate the broader development of eyonis®, Median's AI-powered Software as a Medical Device suite for early... ► Artikel lesen | |
| 13.10.25 | Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders' Ordinary and Extraordinary General Meeting on October 31, 2025 | 294 | Business Wire | Regulatory News:
The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company") are invited to participate in the Shareholders' Ordinary and Extraordinary... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALANTIR TECHNOLOGIES | 115,84 | +0,54 % | Nach Kurssturz: Palantir-Aktie vor Comeback? Analyst sieht enormes Kurspotenzial | © Foto: Dall-EMizuho sieht im jüngsten Kursrutsch von Palantir eine Fehlbewertung und setzt auf eine kräftige Erholung dank boomender KI-Nachfrage.Die Investmentbank Mizuho hat die Aktie von Palantir... ► Artikel lesen | |
| ORACLE | 122,92 | -3,47 % | Oppenheimer sieht Potenzial: Oracle: Kann diese Aktie nach dem Rückgang jetzt richtig abheben? | © Foto: Richard Vogel/AP/dpaOppenheimer hebt Oracle auf "outperform" und hebt das Kursziel an. Ist der Zeitpunkt für den Einstieg jetzt gekommen?Oppenheimer sieht im jüngsten starken Rückgang der Oracle-Aktien... ► Artikel lesen | |
| SHOPIFY | 102,44 | -4,01 % | TxtCart Accelerates Growth as Bootstrapped AI-Powered SMS Marketing Platform for Shopify | Company Surpasses $100M in Merchant-Generated Revenue While Remaining Fully BootstrappedNEW YORK, Feb. 24, 2026 /PRNewswire/ -- TxtCart, a leading AI-powered SMS marketing platform built... ► Artikel lesen | |
| CROWDSTRIKE | 309,05 | -4,30 % | Aktien unter Druck! PayPal, IBM, Microsoft, Crowdstrike, Bitcoin | In der Sendung stehen zunächst die schwachen US-Börsen im Fokus: Neue Zoll-Sorgen (15 Prozent) und Trumps Aussagen sorgen für Nervosität, die Volatilität zieht an. Große Impulse fehlen, daher richtet... ► Artikel lesen | |
| D-WAVE QUANTUM | 15,255 | -10,55 % | D-Wave Quantum Aktie: Verdoppler oder Verdreifacher möglich! Wieder auf 40 US-Dollar? Jetzt den Rebound nicht verpassen! | © Foto: Pixabay auf PexelsQuantencomputer klingen nach Science-Fiction. Doch D-Wave macht seit fast drei Jahrzehnten echtes Geld damit und das Unternehmen zieht gerade alle Register. Ein frischer Hauptsitz... ► Artikel lesen | |
| ATOSS SOFTWARE | 87,70 | -0,68 % | EQS-DD: ATOSS Software SE: AOB Invest GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
25.02.2026 / 16:47... ► Artikel lesen | |
| ZOOM COMMUNICATIONS | 61,72 | -3,59 % | Ihre wichtigsten Termine: Heute im Fokus: Salesforce, Nvidia, Bayer, Zoom, Nasdaq, Snowflake und Eon | © Foto: © Copyright 2024 Salesforce, incGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
| VEEVA SYSTEMS | 153,00 | -1,26 % | Stifel cuts Veeva Systems stock price target on margin concerns | ||
| BRAINCHIP | 0,092 | +5,84 % | Why Bapcor, Brainchip, Coles, and Harvey Norman shares are dropping today | ||
| GEN DIGITAL | 19,500 | +0,52 % | Gen Digital Inc.'s (GEN) LifeLock Software Expands Identity Protection Plans For Americans | ||
| VERSES AI | 0,459 | -38,80 % | VERSES AI Inc.: VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025 | ||
| GRAB | 3,627 | -0,58 % | Singapore's Grab bets on AI, new services to triple profit by 2028 | ||
| SENTINELONE | 10,950 | -4,37 % | SentinelOne Unveils AI-Native Identity Security for Humans and Machines | ||
| TREND MICRO | 28,160 | -0,85 % | Trend Micro Apex One: Malware-Schutz mit kritischen Sicherheitslücken | ||
| MITEK SYSTEMS | 12,380 | -0,40 % | MITEK SYSTEMS INC - 8-K, Current Report |